首页> 外文期刊>Leukemia and lymphoma >Detection of the Der (21)t(12;21) chromosome forming the TEL-AML1 fusion gene in childhood acute lymphoblastic leukemia.
【24h】

Detection of the Der (21)t(12;21) chromosome forming the TEL-AML1 fusion gene in childhood acute lymphoblastic leukemia.

机译:在儿童急性淋巴细胞白血病中检测形成TEL-AML1融合基因的Der(21)t(12; 21)染色体。

获取原文
获取原文并翻译 | 示例
           

摘要

The t(12;21) (p13;q22) is observed in approximately 20-25% of childhood B-lineage acute lymphoblastic leukemia (ALL) cases in both Asian and Caucasian populations. This translocation results in the fusion of TEL, a recently described ETS-like gene on 12p13, and AML1, which was shown to be involved in the formation of fusion genes with ETO and EVI1 in myeloid leukemias. Fluorescence in situ hybridization (FISH) and reverse transcriptase-polymerase chain reaction (RT-PCR) analysis are useful in detecting this translocation which is not readily identified with routine cytogenetic techniques. The t(12;21) is associated with a distinct subgroup of patients characterized by an age between 1 and 10 years, an early B immunophenotype, and a good prognosis. A high incidence of the deletion of non-translocated TEL is another characteristic of leukemic cells with this translocation. TEL-AML1 hybrid protein thought to be critical in leukemogenesis possesses the HLH domain of TEL fused to almost the entire AML1 protein, although the detailed mechanisms of leukemogenesis remain obscure. RT-PCR combined with FISH analysis of posttreatment samples appears to be useful in detecting early relapse or minimal residual disease and thus, is expected to optimize the treatment strategy for patients with t(12;21).
机译:在亚洲和高加索人群中,约20-25%的儿童B系急性淋巴细胞白血病(ALL)病例中观察到t(12; 21)(p13; q22)。这种易位导致TEL(最近在12p13上描述的ETS样基因)与AML1融合,后者被证明与髓样白血病中ETO和EVI1融合基因的形成有关。荧光原位杂交(FISH)和逆转录聚合酶链反应(RT-PCR)分析可用于检测这种易位,这是常规细胞遗传学技术不易鉴定的。 t(12; 21)与年龄在1至10岁之间,早期B免疫表型和良好预后的患者亚群相关。非易位TEL缺失的高发生率是具有这种易位的白血病细胞的另一特征。尽管白血病发生的详细机制仍然不清楚,但被认为在白血病发生中至关重要的TEL-AML1杂合蛋白拥有TEL的HLH结构域,该域与几乎整个AML1蛋白融合。 RT-PCR结合后处理样品的FISH分析似乎可用于检测早期复发或最小残留疾病,因此有望优化t(12; 21)患者的治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号